Twist Bioscience Corporation filed a Form 8-K on August 19, 2026, disclosing the filing of a prospectus supplement to register the resale of shares issuable to Invenra Inc. under agreements dated February 11, 2026.

Key Highlights

  • Prospectus supplement filed: Twist Bioscience is registering the resale of shares issuable to Invenra Inc. pursuant to a Stock Purchase Agreement dated February 11, 2026.
  • Registration Rights Agreement: The filing is made pursuant to a Registration Rights Agreement dated February 11, 2026, between Twist Bioscience Corporation and Invenra Inc.
  • Legal opinion included: An opinion of Orrick, Herrington and Sutcliffe LLP is filed as Exhibit 5.1 in connection with the registration of the resale of the shares.
  • Exchange listing: Common stock trades under the symbol TWST on NASDAQ:TWST (The Nasdaq Global Select Market).
  • Signed by: Judy Yan, Assistant General Counsel and Assistant Secretary, on behalf of Twist Bioscience Corporation.

Twist Bioscience Registers Invenra Share Resale Under February 2026 Agreements

According to the filing, Twist Bioscience Corporation reported the event under Item 8.01 (Other Events). The company disclosed that, pursuant to a Registration Rights Agreement dated February 11, 2026, entered into between Twist Bioscience and Invenra Inc., it is filing a prospectus supplement to register the resale of shares issuable under a Stock Purchase Agreement of the same date between the two parties.

The filing does not disclose the number of shares to be registered, the purchase price per share, or the total value of the Stock Purchase Agreement. The current report attaches as Exhibit 5.1 a legal opinion from Orrick, Herrington and Sutcliffe LLP in connection with the registration of the resale of the shares. No financial statements were included in this filing.

The Form 8-K was signed on August 19, 2026, by Judy Yan, Assistant General Counsel and Assistant Secretary of Twist Bioscience Corporation, a Delaware-incorporated company headquartered at 681 Gateway Boulevard, South San Francisco, CA 94080.

What Was Disclosed

Twist Bioscience filed an 8-K on August 19, 2026, disclosing a prospectus supplement registration for the resale of shares issuable to Invenra Inc. under a Stock Purchase Agreement and Registration Rights Agreement, both dated February 11, 2026.